The Second Annual OIS@ASCRS – Ophthalmology Innovation Summit at the American Society of Cataract and Refractive Surgery was held in San Francisco on April 18, 2013. The conference attracted 325 attendees from 29 US states and 21 countries.
The purpose of OIS is to create an ecosystem of clinical, technology and business. Uniting this diverse group of key players in the ophthalmic field fosters innovation and facilitates business transactions. The conference provides a forum for addressing key issues impacting the ophthalmic field and a platform to showcase the most promising private ophthalmic companies. During this year’s Summit, William J. Link, PhD, OIS Co-Chair and Managing Director, Versant Ventures, said, “OIS is resonating because in the same room we’re bringing together the inventors, the early adopting clinicians, the sources of capital and industry—those four constituencies that are required to power innovation.”
Key topics at the Summit included the funding of ophthalmic innovation, process improvements at the US Food and Drug Administration (FDA), as well as the emerging fields of refractive cataract surgery, presbyopia correction, and micro-invasive glaucoma surgery (MIGS).